Luca Porcu

机构：University of Cambridge, Cancer Research UK, Cancer Research UK Cambridge Center · ORCID：0000-0002-0911-9775

发表论文 228 篇 · 总被引 3607 次 · h-index 31

代表论文

• Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC (2024 · Journal of Thoracic Oncology · 被引 86)
• Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study (2023 · Clinical Kidney Journal · 被引 31)
• Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial (2023 · BMC Cancer · 被引 15)
• Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment (2024 · Oncogene · 被引 14)
• From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma (2024 · Cancers · 被引 10)
• Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset (2023 · Annals of Clinical and Translational Neurology · 被引 7)